Skip to main contentSkip to navigation
Sirius Investors

PXRB Stock: PixarBio Corporation Stock Price, Analysis & Insights

Get live PXRB stock price $0.00, comprehensive PixarBio Corporation stock analysis, charts, news, and expert forecast. Real-time PXRB stock data and investment insights.

0.00
0.00%Today
PXRBPixarBio Corporation • Other OTC • Consumer Cyclical
Market Cap
82
Volume
300
52W High
0.00
52W Low
0.00

Loading chart data...

Investment Score

Annual (latest period)
Unavailable

A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.

Score unavailable for this asset.

0-39

Defensive posture

40-54

Mixed / wait for confirmation

55-69

Constructive setup

70-100

Attractive zone

Total Score

Value

Cheapness vs fundamentals and cash generation

Quality

Durability of profitability and balance sheet

Momentum

Price trend strength and persistence

Professional usage: treat the score as a ranking and risk-filtering tool, then confirm with earnings revision trend, competitive positioning, and valuation relative to peers before capital allocation.

Company Overview

PixarBio Corporation operates as a specialized pharmaceutical and biotechnology firm, primarily dedicated to the pre-clinical and clinical advancement of neurological drug delivery systems. Initially, their focus is on alleviating post-surgical pain....

Company Information

CEO
Francis M. Reynolds
Sector
Consumer Cyclical
Industry
Personal Products & Services
Employees
30

Contact Information

Website
Address
Country
US

Investment Analysis & Business Insights

Consumer Cyclical
Personal Products & Services

Investment Highlights

Strong presence in the Consumer Cyclical sector with established market position

Lower volatility stock (Beta: -55.70) may provide portfolio stability

Important Investment Considerations

  • All investments carry risk, including potential loss of principal for PixarBio Corporation shareholders
  • Market volatility can significantly impact stock price, especially for smaller companies
  • Sector-specific risks in Consumer Cyclical may affect company performance
  • Past performance does not guarantee future results for PixarBio Corporation
  • Investors should consider how PixarBio Corporation fits within their overall portfolio allocation
  • Valuation metrics suggest potential, but require fundamental analysis

Market Cap

82

P/E Ratio (TTM)

-0.00

Beta

-55.70

Data Sources & Methodology

Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.

About Consumer Cyclical Sector

The Consumer Cyclical sector includes companies that sell non-essential goods and services that consumers purchase when they have disposable income.